20043 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Pulmonary tract; Aromatherapy; Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Pharmaceutical compositions of dextran polymer derivatives and a carrier material
#1202Dry Powder Formulations, Vaccines and Methods
#1203METHOD OF PRODUCING A NICOTINE MEDICAMENT AND A MEDICAMENT MADE BY THE METHOD
#1204COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#1205Method for treating hyperglycemia
#1206Spray drying methods and related compositions
#1207AMELIORATING AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#1208Dry powder formulation comprising a phosphodiesterase inhibitor
#1209Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
#1210PROCESS FOR PREPARING PYRROLIDINIUM SALTS
#1211Use of simple amino acids to form porous particles
#1212Diketopiperazine microparticles with defined specific surface areas
#1213Treatment of bacterial diseases of the respiratory organs
#1214Methods and compositions for delivery of medicaments to the lungs
#1215Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
#1216Use of A2B Adenosine Receptor Antagonists for Treating Pulmonary Hypertension
#1217Pharmaceutical compositions of dextran polymer derivatives
#1218Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
#1219Novel embedment particles for inhalation
#1220INHALABLE PARTICLES COMPRISING TIOTROPIUM
#1221Stabilized pharmaceutical product
#1222DRY POWDER FORMULATION COMPRISING AN ANTIMUSCARINIC DRUG
#1223Bacteriophage compositions for treatment of bacterial infections
#1224PHARMACEUTICAL POLYPEPTIDE DRY POWDER AEROSOL FORMULATION AND METHOD OF PREPARATION
#1225PHARMACEUTICAL POLYPEPTIDE DRY POWDER AEROSOL FORMULATION AND METHOD OF PREPARATION
#1226Process for preparing carrier particles for dry powders for inhalation
#1227PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
#1228PULMONARY DELIVERY OF 17-HYDROXYPROGESTERONE CAPROATE (17-HPC)
#1229Biologic scaffold for prevention of pulmonary fibrosis
#1230INHALANT COMPRISING MODIFIED SUPEROXIDE DISMUTASE
#1231Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation
#1232Dry powder pharmaceutical composition for inhalation
#1233FORMULATIONS CONTAINING LARGE-SIZE CARRIER PARTICLES FOR DRY POWDER INHALATION AEROSOLS
#1234Methods and compositions for administration of oxybutynin
#1235Inhalable epinephrine
#1236Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives
#1237INHIBITION OF INTER-ALPHA TRYPSIN INHIBITOR FOR THE TREATMENT OF AIRWAY DISEASE
#1238ENGINEERING POROUS PARTICLES OF WATER SOLUBLE THERAPEUTICS FOR PRESSURIZED METERED-DOSE INHALER FORMULATIONS
#1239Nanoparticles and Porous Particles and Methods of Making the Same
#1240Nanocluster compositions and methods
#1241PULMONARY DISEASE TREATMENT
#1242NAPADISYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA 2 ADRENERGIC RECEPTOR
#1243Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#1244Superior Control of Blood Glucose in Diabetes Treatment
#1245Apparatus and Method for Continuous Production of Spherical Powder Agglomerates
#1246Dronabinol Treatment for Migraines
#1247USE OF OSMOLYTES OBTAINED FROM EXTREMOPHILIC BACTERIA FOR THE PRODUCTION OF INHALABLE MEDICAMENTS FOR THE PROPHYLAXIS AND TREATMENT OF PULMONARY AND CARDIOVASCULAR DISEASES AND AN INHALATION DEVICE COMPRISING OSMOLYTE AS ACTIVE AGENT COMPONENT
#1248Pulmonary delivery for levodopa
#1249Methods for preparing pharmaceuticals by emulsion aggregation processes
#1250Process for improving crystallinity
#1251INHALABLE COMPOSITIONS HAVING ENHANCED BIOAVAILABILITY
#1252Tobramycin magnesium stearate microparticles for inhalation, compositions thereof, and methods of making and using the same
#1253METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
#1254COMBINATION OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#1255Process for making micro-sized protein particles
#1256INHALED FOSFOMYCIN/TOBRAMYCIN FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#1257Pulmonary delivery of a fluoroquinolone
#1258INHALABLE SUSTAINED THERAPEUTIC FORMULATIONS
#1259Quinuclidine derivatives and medicinal compositions containing the same
#1260Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#1261Dry Powder for Inhalation
#1262Airflow adaptor for a breath-actuated dry powder inhaler
#1263DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATES
#1264Methods and compositions for delivering peptides
#1265Method of making a dry powder pharmaceutical composition
#1266Formulation of Fine Particles Using Liquefied or Dense Gases
#1267METHODS OF INHIBITING THE FORMATION OF AMYLOID-BETA DIFFUSABLE LIGANDS USING ACYLHYDRAZIDE COMPOUNDS
#1268METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS
#1269PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-QUINOLINONE HAVING IMPROVED ADHESION PROPERTIES FOR POWDER FORMULATIONS FOR INHALATION
#1270Sealed capsule including an integrated puncturing mechanism
#1271Headache pre-emption by dihydroergotamine treatment during headache Precursor events
#1272Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
#1273DRY POWDER COMPOSITIONS FOR RNA INFLUENZA THERAPEUTICS
#1274Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
#1275METHODS AND COMPOSITIONS FOR TREATMENT OF RAYNAUD'S PHENOMENON
#1276Pharmaceutical formulation comprising a water-insoluble active agent
#1277Process for manufacturing flowable powder drug compositions
#1278Stable pharmaceutical products
#1279ZWITTERIONIC IMMUNOMODULATORS FOR THE TREATMENT OF ASTHMA AND ALLERGY
#1280Respiratory disease treatment
#1281Process for producing nanoparticles
#1282SURFACE-MODIFIED NANOPARTICLES
#1283MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A STEROID
#1284Intranasal pharmaceutical compositions with improved pharmacokinetics
#1285Antiviral drugs for treatment of arenavirus infection
#1286COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1287COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTERIODS
#1288COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1289NOVEL DOSAGE AND FORMULATION
#1290USE OF 5-AMINOLEVULINIC ACID AND DERIVATIVES IN A SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSIS
#1291NOVEL DOSAGE AND FORMULATION
#1292METHOD OF PROPHYLAXIS AND AGENTS FOR USE THEREIN
#1293Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
#1294Diketopiperazine salts for drug delivery and related methods
#1295Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation
#1296CERIA FOR USE AS AN ANTIMICROBIAL BARRIER AND DISINFECTANT IN A WOUND DRESSING
#1297Carrier particles for use in dry powder inhalers
#1298MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC
#1299Spray freeze dry of compositions for pulmonary administration
#1300Respiratory dispersion for metered dose inhalers comprising perforated microstructures
#1301Inhalable solid amorphous particles comprising tiotropium bromide and a co-solid
#1302COMPOSITION
#1303DRY POWDER MICROPARTICLES FOR PULMONARY DELIVERY
#1304Pharmaceutical compositions based on anticholingerics and additional active ingredients
#1305Dry powder inhaler system
#1306Airway Administration of Activated Protein C in Inflammatory Conditions Affecting the Respiratory Tract
#1307Composition, device, and method for treating sexual dysfunction via inhalation
#1308COMPOSITIONS FOR TREATING PARKINSON'S DISEASE
#1309Method of making particles for use in a pharmaceutical composition
#1310Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
#1311Airway Administration of Site-Inactived FVIIA in Inflammatory Conditions Affecting the Respiratory Tract
#1312Pulmonary delivery particles comprising an active agent
#1313RADIOLABELLED MICROPARTICLES, PROCESSES FOR THE PREPARATION THEREOF AND THE USE THEREOF
#1314INHALATION PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO] ETHYL]-2(1H)-QUINOLINONE AND A CORTICOSTEROID
#1315Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
#1316Organic Compounds
#1317NOVEL COMBINATIONS
#1318Pharmaceutical compositions of pyrimidine-2,4,6-triones
#1319INHALER DEVICES AND BESPOKE PHARMACEUTICAL COMPOSITIONS
#1320Synthesis of small particles
#1321Stabilized pharmaceutical product
#1322Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles
#1323DRY-POWDER MEDICAMENT
#1324Quinuclidine derivatives and medicinal compositions containing the same
#1325POWDER FORMULATIONS FOR INHALATION CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS
#1326Powder filling processes
#1327Method of Producing Porous Microparticles
#1328Compositions and methods of making brittle-matrix particles through blister pack freezing
#1329DRUG CAPSULES FOR DRY POWDER INHALERS
#1330Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction
#1331Method of making particles for use in a pharmaceutical composition
#1332Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#1333MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#1334MEDICAMENT COMPOSITIONS CONTAINING ANTICHOLINERGICALLY-EFFECTIVE COMPOUNDS AND BETAMIMETICS
#1335Method of treating diabetes
#1336Dry powder drug delivery system
#1337DELIVERY OF FLU ANTIBODIES TO SURFACES IN CONTACT WITH AIR
#1338INHALATION DELIVERY METHODS AND DEVICES
#1339Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as Carrier
#1340Novel Process
#1341Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
#1342Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
#1343Aerosolized fluoroquinolones and uses thereof
#1344Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract
#1345Aerosolized fluoroquinolones and uses thereof
#1346Organic Compounds
#1347METHOD FOR MIXING POWDERS
#1348Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
#1349Hemophilia Treatment by Inhalation of Coagulation Factors
#1350SOLID LIPIDIC PARTICLES AS PHARMACEUTICALLY ACCEPTABLE FILLERS OR CARRIERS FOR INHALATION
#1351USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES
#1352Method for treating cystic fibrosis
#1353PHARMACEUTICAL COMPOSITIONS
#1354Pharmaceutical Formulations
#1355Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
#1356Pharmaceutical Anit-Infective Composition for Inhalation
#1357Method of producing porous microparticles
#1358Methods and compositions for delivering peptides
#1359METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
#1360Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
#1361Pharmaceutical anti-infective composition for inhalation
#1362COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS
#1363Stable powder formulation containing an anticholinergic agent
#1364Micronized particles of low-dosage strength active agents for powder formulations for inhalation
#1365COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1366COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1367Stable powder formulation containing a novel anticholinergic agent
#1368PHARMACEUTICAL COMPOSITIONS COMPRISING METHOTREXATE
#1369Aerosolized fluoroquinolones and uses thereof
#1370Aerosolized fluoroquinolones and uses thereof
#1371DRY POWDER FORMULATIONS
#1372NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF
#1373Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content
#1374Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin
#1375Spray drying process control of drying kinetics
#1376COMBINATIONS OF FORMOTEROL AND FLUTICASONE PROPIONATE FOR ASTHMA
#1377Method of making a dry powder formulation
#1378Charging Control in an Electric Vehicle
#1379USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
#1380Composition, device, and method for treating sexual dysfunction via inhalation
#1381Powder Compositions for Inhalation
#1382Pharmaceutical preparations and their manufacture
#1383Method of prophylaxis of infection
#1384NOVEL COMPOSITIONS AND METHODS
#1385Pulmonary Insulin Crystals
#1386Encapsulated tiotropium containing powder formulation for inhalation
#1387Selective Targeting of Apoptotic Cells
#1388Dry powder inhaler and system for drug delivery
#1389Dry powder inhaler and system for drug delivery
#1390Dry powder inhaler and system for drug delivery
#1391PROCESS FOR MANUFACTURING LACTOSE
#1392Systems and processes for spray drying hydrophobic and hydrophilic components
#1393COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#1394Controlled release implantable dispensing device and method
#1395Pharmaceutical formulations for dry powder inhalers
#1396MASKING THE TASTE OF POWDERS
#1397Method of preparing dry powder inhalation compositions
#1398COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTI-IGE ANTIBODY FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#1399Soft anticholinergic esters
#1400Pharmaceutical compounds and compositions
#1401COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT
#1402Soft anticholinergic zwitterions
#1403Soft steroid compositions for use in dry powder inhalers
#1404MEDICINAL AEROSOL FORMULATIONS
#1405METHOD OF TREATING DIABETES MELLITUS IN A PATIENT
#1406PROCEDURE AND DEVICES FOR THE CONTROLLED OBTAINING OF DRY SALINE AEROSOLS WITH THERAPEUTIC EFFECT
#1407Cell Transport Compositions and Uses Thereof
#1408Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension
#1409COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION
#1410Templated open flocs of anisotropic particles for enhanced pulmonary delivery
#1411Methods for limiting spread of pulmonary infections
#1412Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
#1413METHODS AND COMPOSITONS FOR PULMONARY DELIVERY OF INSULIN
#1414AEROSOLIZED NITRITE AND NITRIC OXIDE -DONATING COMPOUNDS AND USES THEREOF
#1415DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG
#1416MEDICAL PRODUCT
#1417AEROSOL AND USE THEREOF
#1418MEDICAL PRODUCT CONTAINING TIOTROPIUM
#1419INHALABLE TIOTROPIUM AND CONTAINER THEREFOR
#1420PRE-METERED DRY POWDER INHALER FOR MOISTURE-SENSITIVE MEDICAMENTS
#1421INHALABLE DRUG
#1422Capsule for taking an active substance which can be inhaled
#1423Propellant-based nanoparticulate dry powder aerosols and method of making
#1424COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#1425Nanocomposite particles
#1426PULMONARY DELIVERY IN TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM
#1427MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC
#14283-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#1429Aminotetralin compounds as mu opioid receptor antagonists
#1430Solid peptide preparations for inhalation and their preparation
#1431Capsules Containing Inhalable Tiotropium
#1432Dry powder inhalation system for transpulmonary administration
#1433Compositions comprising an active agent
#1434COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS
#1435Delivery of active agents
#1436Methods and compositions for pulmonary administration of a TNFa inhibitor
#1437DEVICE FOR INHALATION OF MEDICINE
#1438Pulmonary pharmaceutical formulations
#1439Nanoencapsulation of Proteins
#1440COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1441PHARMACEUTICAL COMPOSITIONS CONTAINING WATER-SOLUBLE DERIVATIVES OF PROPOFOL AND METHODS OF ADMINISTERING SAME VIA PULMONARY ADMINISTRATION
#1442Technology for the Preparation of Microparticles
#1443Dry powder inhalation system for transpulmonary administration
#1444COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1445DEHYDROEPIANDROSTERONE SULFATE DIHYDRATE INHALATION COMPOSITIONS AND METHODS
#1446PULMONARY DELIVERY OF POLYENE ANTIFUNGAL AGENTS
#1447Soft anticholinergic esters
#1448Pharmaceutical compositions
#1449Process for the manufacture of powders of inhalable medicaments
#1450HIGHLY EFFICIENT DELIVERY OF A LARGE THERAPEUTIC MASS AEROSOL
#1451Acetamide stereoisomer
#1452Phospholipid-based powders for drug delivery
#1453Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
#1454Inhalation Device Containing Plural Doses of a Pharmaceutical Composition
#1455MEDICAL PRODUCT
#1456Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough, asthma and tussive attacks
#1457MEDICAL PRODUCT CONTAINING TIOTROPIUM
#1458Storage stable powder compositions of interleukin-4 receptor
#1459Process for Crystallizing Lactose Particles for Use in Pharmaceutical Formulations
#1460Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#1461Pre-metered dry powder inhaler for moisture-sensitive medicaments
#1462PARTICLE AND PREPARATION CONTAINING THE PARTICLE
#1463Methods of modifying amyloid β oligomers using non-peptidic compounds
#1464Nucleic acid microparticles for pulmonary delivery
#1465Compositions and methods for the treatment of respiratory disorders
#1466INHALABLE TIOTROPIUM AND CONTAINER THEREFOR
#1467Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
#1468Delivery of oral drugs
#1469BREAKTHROUGH PAIN MANAGEMENT
#1470Pulmonary insulin crystals
#1471Method of particle formation
#1472Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
#1473Nanoparticulate formulations and methods for the making and use therof
#1474DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE
#1475DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE
#1476Organic Compounds Comprising a Glycopyrrolium Salt
#1477METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN
#1478Respirable Powders
#1479Inhalable Powder Containing Tiotropium
#1480Pre-metered dry powder inhaler for moisture-sensitive medicaments
#1481Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
#1482Salt Il
#1483Combination Of Dehydroepiandrosterone Or Dehydroepiandrosterone-Sulfate With An Anticholinergic Bronchodilator For Treatment Of Asthma Or Chronic Obstructive Pulmonary Disease
#1484Organic Compounds Comprising a Glycopyrr Onium Salt
#1485Method of Treating Diabetes Mellitus in a Patient
#1486Pulmonary Formulation
#1487GLUCAGON-LIKE PEPTIDE 1 (GLP-1) PHARMACEUTICAL FORMULATIONS
#1488Inhalation particles incorporating a combination of two or more active ingredients
#1489Particles for inhalation having sustained release properties
#1490Production method of drug containing composite particle
#1491Soft anticholinergic zwitterions
#1492METHOD FOR THE ADMINISTRATION OF AN ANTICHOLINERGIC BY INHALATION
#1493Dispersion for pulmonary delivery of a bioactive agent
#1494Salt I
#1495PARTICLES FOR INHALATION HAVING RAPID RELEASE PROPERTIES
#1496Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions obtained from the same and process for their preparation
#1497PARTICLES FOR INHALATION HAVING RAPID RELEASE PROPERTIES
#1498Respiratory dispersion for metered dose inhalers
#1499Quinuclidine derivatives and medicinal compositions containing the same
#1500Treatment of respiratory diseases